Viking Liabilities And Stockholders Equity from 2010 to 2025

VKTX Stock  USD 34.07  2.44  7.71%   
Viking Therapeutics Liabilities And Stockholders Equity yearly trend continues to be fairly stable with very little volatility. Liabilities And Stockholders Equity is likely to outpace its year average in 2025. Liabilities And Stockholders Equity is the total of all liabilities and equity in the company, which should equal Viking Therapeutics' total assets according to the accounting equation. View All Fundamentals
 
Liabilities And Stockholders Equity  
First Reported
2014-03-31
Previous Quarter
946.8 M
Current Value
937.9 M
Quarterly Volatility
242.5 M
 
Yuan Drop
 
Covid
Check Viking Therapeutics financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Viking Therapeutics' main balance sheet or income statement drivers, such as Depreciation And Amortization of 319 K, Interest Expense of 75.2 K or Selling General Administrative of 44.7 M, as well as many indicators such as Price To Sales Ratio of 0.0, Dividend Yield of 0.0 or PTB Ratio of 4.76. Viking financial statements analysis is a perfect complement when working with Viking Therapeutics Valuation or Volatility modules.
  
Check out the analysis of Viking Therapeutics Correlation against competitors.
For more information on how to buy Viking Stock please use our How to Invest in Viking Therapeutics guide.

Latest Viking Therapeutics' Liabilities And Stockholders Equity Growth Pattern

Below is the plot of the Liabilities And Stockholders Equity of Viking Therapeutics over the last few years. It is the total of all liabilities and equity in the company, which should equal the company's total assets according to the accounting equation. Viking Therapeutics' Liabilities And Stockholders Equity historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Viking Therapeutics' overall financial position and show how it may be relating to other accounts over time.
Liabilities And Stockholders Equity10 Years Trend
Slightly volatile
   Liabilities And Stockholders Equity   
284.256.210.168.368.423.445.-10%-18%-20%119%15%5%100%
       Timeline  

Viking Liabilities And Stockholders Equity Regression Statistics

Arithmetic Mean157,207,944
Geometric Mean20,357,114
Coefficient Of Variation107.65
Mean Deviation150,225,328
Median168,529,000
Standard Deviation169,239,312
Sample Variance28641.9T
Range444.8M
R-Value0.89
Mean Square Error6426.5T
R-Squared0.79
Slope31,606,898
Total Sum of Squares429629.2T

Viking Liabilities And Stockholders Equity History

2025445 M
2024423.8 M
2023368.5 M
2022168.5 M
2021210.7 M
2020256.5 M
2019284.3 M

About Viking Therapeutics Financial Statements

Viking Therapeutics investors use historical fundamental indicators, such as Viking Therapeutics' Liabilities And Stockholders Equity, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Viking Therapeutics. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Liabilities And Stockholders Equity423.8 M445 M

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for Viking Stock Analysis

When running Viking Therapeutics' price analysis, check to measure Viking Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Viking Therapeutics is operating at the current time. Most of Viking Therapeutics' value examination focuses on studying past and present price action to predict the probability of Viking Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Viking Therapeutics' price. Additionally, you may evaluate how the addition of Viking Therapeutics to your portfolios can decrease your overall portfolio volatility.